ELCC25

Benjamin Besse discussed de-escalation strategies in patient management and clinical trials at ELCC25

Eric Singhi: How MARIPOSA and MARIPOSA-2 studies differ

Jarushka Naidoo: Signing off on another great ELCC25

Serre-Beinier Veronique: Key Insights from ELCC 2025

Cecilia Pompili: PROs research from ELCC25 on NSCLC treatment and thoracic surgery

Highlights from ELCC 2025

The lung cancer patient advocacy sessions at the ELCC 2025 were standout events – Lung Cancer Europe

Jarushka Naidoo: My ELCC 2025 Top 3 – MARIPOSA, KRYSTAL7 and Deescalation trials

How PROs and CROs provide different but equally vital information – ESMO

IASLC – ELCC2025 has been an incredible opportunity to foster collaboration and reconnect